Literature DB >> 16634834

Stem cells in the lung parenchyma and prospects for lung injury therapy.

C C Yen1, S H Yang, C Y Lin, C M Chen.   

Abstract

Until recently, it was thought that only embryonic stem cells were pluripotent and that adult stem cells were restricted in their differentiative and regenerative potential to become the tissues in which they reside. However, the discovery that adult stem cells in one tissue can contribute to the formation of other tissues, especially after injury or cell damage, implies that stem cells have developmental plasticity. For example, haematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) from bone marrow can be used to regenerate diverse tissues at distant sites, including the lung. This article reviews the character of stem cells in the lung parenchyma and focuses on the potential uses of adult stem cells in research of lung injury and lung disease therapies.

Entities:  

Mesh:

Year:  2006        PMID: 16634834     DOI: 10.1111/j.1365-2362.2006.01638.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  5 in total

Review 1.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

2.  Design and development of tissue engineered lung: Progress and challenges.

Authors:  Joan E Nichols; Jean A Niles; Joaquin Cortiella
Journal:  Organogenesis       Date:  2009-04       Impact factor: 2.500

3.  Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis.

Authors:  Shin-Hwa Lee; An-Soo Jang; Young-Eun Kim; Ji-Yeon Cha; Tae-Hoon Kim; Seok Jung; Seong-Kyu Park; You-Kyoung Lee; Jong-Ho Won; Yong-Hoon Kim; Choon-Sik Park
Journal:  Respir Res       Date:  2010-02-08

Review 4.  New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy.

Authors:  Mehrnaz Gharaee-Kermani; Margaret R Gyetko; Biao Hu; Sem H Phan
Journal:  Pharm Res       Date:  2007-03-01       Impact factor: 4.580

5.  [New therapeutic strategies in ARDS].

Authors:  S Gaudry; D Dreyfuss; J-D Ricard
Journal:  Reanimation       Date:  2012-11-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.